Review
Published on 17 Aug 2023
The immunomodulatory effect of lithium as a mechanism of action in bipolar disorder
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2023.1213766
- 7,057 views
- 9 citations
Type at least 3 characters
1,039 articles
Review
Published on 08 Aug 2023
Antidepressant mechanisms of ketamine: a review of actions with relevance to treatment-resistance and neuroprogression
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2023.1223145
- 8,552 views
- 39 citations
Editorial
Published on 08 Aug 2023
Editorial: Traditional medicine and phytochemicals for neurodegenerative diseases treatment: application of interdisciplinary technologies in novel therapeutic target and drug discovery
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2023.1268710
- 2,286 views
- 4 citations
Review
Published on 07 Aug 2023
The emerging role of copper in depression
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2023.1230404
- 12,408 views
- 14 citations
Original Research
Published on 03 Aug 2023
A brief exposure to toluene vapor alters the intrinsic excitability of D2 medium spiny neurons in the rat ventral striatum
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2023.1235866
- 1,529 views
- 2 citations
Review
Published on 01 Aug 2023
Non-canonical pathways in the pathophysiology and therapeutics of bipolar disorder
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2023.1228455
- 8,316 views
- 7 citations
Original Research
Published on 28 Jul 2023
Pioglitazone enhances brain mitochondrial biogenesis and phase II detoxification capacity in neonatal rats with 6-OHDA-induced unilateral striatal lesions
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2023.1186520
- 2,576 views
- 5 citations
Mini Review
Published on 24 Jul 2023
Attenuation of ferroptosis as a potential therapeutic target for neuropsychiatric manifestations of post-COVID syndrome
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2023.1237153
- 3,275 views
- 5 citations
Editorial
Published on 21 Jul 2023
Editorial: Mechanism and pharmacodynamic material basis of neurodegenerative disease therapies
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2023.1254881
- 1,513 views
- 2 citations
Editorial
Published on 18 Jul 2023
Editorial: What does it take to cure the brain? Studies toward genes, proteins, processes, and rehabilitation
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2023.1252955
- 1,095 views
Systematic Review
Published on 14 Jul 2023
The cellular mechanisms associated with the anesthetic and neuroprotective properties of xenon: a systematic review of the preclinical literature
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2023.1225191
- 4,858 views
- 9 citations
Review
Published on 13 Jul 2023
Influence of glutamatergic and GABAergic neurotransmission on obstructive sleep apnea
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2023.1213971
- 12,158 views
- 21 citations
Original Research
Published on 11 Jul 2023
Central nervous system-related safety and tolerability of add-on ketamine to standard of care treatment in treatment-resistant psychotic depression in patients with major depressive disorder and bipolar disorder
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2023.1214972
- 2,730 views
- 5 citations
Editorial
Published on 07 Jul 2023
Editorial: Innovative treatments for neuro-psychiatric diseases
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2023.1247681
- 1,739 views
- 1 citation
Original Research
Published on 30 Jun 2023
In silico evaluation of the role of lisdexamfetamine on attention-deficit/hyperactivity disorder common psychiatric comorbidities: mechanistic insights on binge eating disorder and depression
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2023.1118253
- 5,142 views
- 2 citations
Review
Published on 29 Jun 2023
Neurological adverse events associated with PD-1/PD-L1 immune checkpoint inhibitors
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2023.1227049
- 4,126 views
- 8 citations